CCNDBP1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	30 studies	25% ± 7%	Explore
B cell	21 studies	26% ± 9%	Explore
CD8-positive, alpha-beta T cell	21 studies	23% ± 7%	Explore
CD4-positive, alpha-beta T cell	19 studies	20% ± 5%	Explore
regulatory T cell	17 studies	27% ± 6%	Explore
naive B cell	16 studies	20% ± 4%	Explore
T cell	15 studies	20% ± 3%	Explore
ciliated cell	14 studies	32% ± 12%	Explore
mature NK T cell	14 studies	24% ± 5%	Explore
memory B cell	14 studies	21% ± 5%	Explore
gamma-delta T cell	13 studies	25% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	11 studies	27% ± 7%	Explore
non-classical monocyte	10 studies	30% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	10 studies	27% ± 9%	Explore
classical monocyte	9 studies	24% ± 11%	Explore
fibroblast	9 studies	21% ± 6%	Explore
erythrocyte	8 studies	41% ± 17%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	25% ± 10%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	22% ± 4%	Explore
conventional dendritic cell	7 studies	28% ± 17%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	28% ± 8%	Explore
mucosal invariant T cell	7 studies	22% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	22% ± 4%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	23% ± 5%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	21% ± 2%	Explore
pericyte	6 studies	21% ± 5%	Explore
epithelial cell	6 studies	36% ± 14%	Explore
mast cell	6 studies	24% ± 7%	Explore
T follicular helper cell	6 studies	21% ± 1%	Explore
plasmacytoid dendritic cell	6 studies	25% ± 8%	Explore
endothelial cell	5 studies	22% ± 4%	Explore
innate lymphoid cell	5 studies	23% ± 4%	Explore
goblet cell	5 studies	20% ± 5%	Explore
plasma cell	4 studies	26% ± 13%	Explore
exhausted T cell	4 studies	31% ± 6%	Explore
smooth muscle cell	4 studies	21% ± 4%	Explore
precursor B cell	4 studies	30% ± 9%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	31% ± 3%	Explore
endothelial cell of lymphatic vessel	4 studies	21% ± 6%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	28% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	22% ± 6%	Explore
hematopoietic precursor cell	3 studies	32% ± 12%	Explore
erythroblast	3 studies	45% ± 28%	Explore
retinal ganglion cell	3 studies	51% ± 27%	Explore
placental villous trophoblast	3 studies	61% ± 15%	Explore
intraepithelial lymphocyte	3 studies	24% ± 6%	Explore
abnormal cell	3 studies	22% ± 3%	Explore
type I pneumocyte	3 studies	23% ± 6%	Explore
GABAergic neuron	3 studies	25% ± 4%	Explore
glutamatergic neuron	3 studies	34% ± 8%	Explore
intestinal crypt stem cell	3 studies	16% ± 1%	Explore
basal cell	3 studies	34% ± 13%	Explore
group 3 innate lymphoid cell	3 studies	24% ± 6%	Explore
T-helper 1 cell	3 studies	22% ± 2%	Explore
hematopoietic stem cell	3 studies	23% ± 5%	Explore
double negative thymocyte	3 studies	29% ± 6%	Explore
neuron	3 studies	34% ± 13%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	12 studies	27% ± 10%	Explore
lung	8 studies	23% ± 10%	Explore
liver	4 studies	34% ± 26%	Explore
lymph node	4 studies	20% ± 3%	Explore
placenta	3 studies	28% ± 14%	Explore
brain	3 studies	26% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	2898.88	1445 / 1445	100%	17.19	183 / 183
stomach	100%	2860.53	359 / 359	100%	16.38	286 / 286
thymus	100%	3720.57	653 / 653	100%	41.43	604 / 605
prostate	100%	2613.84	245 / 245	100%	23.83	501 / 502
lung	100%	3043.19	577 / 578	100%	22.96	1154 / 1155
intestine	100%	2855.07	966 / 966	100%	18.46	525 / 527
bladder	100%	3061.48	21 / 21	100%	21.22	502 / 504
breast	100%	3913.96	459 / 459	99%	23.00	1112 / 1118
kidney	100%	2383.24	89 / 89	99%	25.54	895 / 901
pancreas	99%	1524.98	325 / 328	100%	25.57	178 / 178
skin	100%	3084.41	1809 / 1809	99%	28.01	467 / 472
uterus	100%	2643.06	170 / 170	99%	17.80	453 / 459
ovary	99%	1712.88	179 / 180	99%	15.77	425 / 430
brain	98%	2180.60	2600 / 2642	100%	15.37	703 / 705
adrenal gland	100%	3907.43	258 / 258	95%	25.31	219 / 230
liver	96%	1088.09	217 / 226	98%	13.10	396 / 406
adipose	100%	4109.70	1204 / 1204	0%	0	0 / 0
blood vessel	100%	3974.31	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	35.10	29 / 29
spleen	100%	4251.73	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	19.80	45 / 45
ureter	0%	0	0 / 0	100%	9.72	1 / 1
peripheral blood	100%	7501.52	928 / 929	0%	0	0 / 0
muscle	100%	2769.20	802 / 803	0%	0	0 / 0
heart	98%	2302.44	844 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	98%	22.08	78 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0051726	Biological process	regulation of cell cycle
GO_0016604	Cellular component	nuclear body
GO_0005654	Cellular component	nucleoplasm
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	CCNDBP1
Protein name	Cyclin D1 binding protein 1 Cyclin-D1-binding protein 1 Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)
Synonyms	DIP1 GCIP HHM
Description	FUNCTION: May negatively regulate cell cycle progression. May act at least in part via inhibition of the cyclin-D1/CDK4 complex, thereby preventing phosphorylation of RB1 and blocking E2F-dependent transcription. .
Accessions	ENST00000562553.5 H3BUF4 O95273 ENST00000567434.5 H3BR23 H3BQA6 ENST00000568507.5 ENST00000569745.5 ENST00000565296.5 [O95273-2] ENST00000563065.5 ENST00000300213.9 [O95273-1] ENST00000566515.5 [O95273-2]

CCNDBP1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review